FFG

Frisch Financial Group Portfolio holdings

AUM $430M
1-Year Est. Return 15.35%
This Quarter Est. Return
1 Year Est. Return
+15.35%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$430M
AUM Growth
+$21.1M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
168
New
Increased
Reduced
Closed

Top Buys

1
+$24.6M
2
+$3.93M
3
+$3.84M
4
DYNF icon
BlackRock US Equity Factor Rotation ETF
DYNF
+$3.12M
5
QUAL icon
iShares MSCI USA Quality Factor ETF
QUAL
+$2.42M

Top Sells

1
+$19M
2
+$9.04M
3
+$5.98M
4
QQQE icon
Direxion NASDAQ-100 Equal Weighted Index Shares
QQQE
+$4.6M
5
IBDX icon
iShares iBonds Dec 2032 Term Corporate ETF
IBDX
+$3.35M

Sector Composition

1 Technology 10.11%
2 Communication Services 7.84%
3 Financials 7.53%
4 Healthcare 3.89%
5 Consumer Discretionary 2.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IBKR icon
151
Interactive Brokers
IBKR
$29B
$204K 0.05%
+2,964
UL icon
152
Unilever
UL
$149B
$202K 0.05%
3,410
+25
NRK icon
153
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$886M
$177K 0.04%
17,221
+1,297
ACRE
154
Ares Commercial Real Estate
ACRE
$292M
$88.1K 0.02%
18,907
+578
GERN icon
155
Geron
GERN
$753M
$26.1K 0.01%
19,025
SUUN
156
PowerBank Corp
SUUN
$59M
$22.9K 0.01%
+15,000
RVP icon
157
Retractable Technologies
RVP
$24.8M
$22.7K 0.01%
27,000
IBDW icon
158
iShares iBonds Dec 2031 Term Corporate ETF
IBDW
$2.02B
– –
-901,284
IBDX icon
159
iShares iBonds Dec 2032 Term Corporate ETF
IBDX
$1.36B
– –
-132,456
MPLX icon
160
MPLX
MPLX
$55.3B
– –
-6,098
CL icon
161
Colgate-Palmolive
CL
$64.8B
– –
-2,253
CRSP icon
162
CRISPR Therapeutics
CRSP
$5.1B
– –
-5,359
FPE icon
163
First Trust Preferred Securities and Income ETF
FPE
$6.27B
– –
-507,992
PDEC icon
164
Innovator US Equity Power Buffer ETF December
PDEC
$874M
– –
-38,802
PMAR icon
165
Innovator US Equity Power Buffer ETF March
PMAR
$615M
– –
-12,896
POCT icon
166
Innovator US Equity Power Buffer ETF October
POCT
$1.11B
– –
-36,497
PSX icon
167
Phillips 66
PSX
$55.2B
– –
-1,989
VRTX icon
168
Vertex Pharmaceuticals
VRTX
$110B
– –
-1,614
3 4 5 6
7